A wafer-scale jump, and a paper wall to match

Recently in August 2026, Adisyn (ASX:AI1) said it had grown a continuous graphene layer across a full 200mm semiconductor wafer at temperatures below 300 degrees Celsius, a roughly 314-square-centimetre surface that is about 300 times larger than the fingernail-sized coupon it demonstrated earlier in the year. The claim was checked at 12 points across all four quadrants of the wafer, measured five times each, and independently verified at the Hebrew University of Jerusalem. Coming barely a fortnight after the tiny Australian company had a second US Patent allowed, the result gives investors two things at once: proof the process scales, and a widening legal fence around it. Both matter far more than the share of the market has yet settled on.

 

What just happened

The 200mm run is the headline, but it lands on top of a busy few months. Earlier in the year, Adisyn had its first US patent allowed, covering a method of growing graphene inside existing chip-factory equipment at factory-safe temperatures. More recently, a second US patent was allowed, protecting the finished product itself, graphene-coated interconnects and surfaces, regardless of how they are made. That second filing specifies copper with a median grain size under 0.9 microns, no separate diffusion-barrier coating, and graphene free of nitrogen doping. In plain terms, Adisyn is trying to own both the recipe and the cake.

Management says the 200mm milestone arrived ahead of its internal schedule and that full, uniform industrial coverage of the wafer is expected “within just a few months.” Managing Director Arye Kohavi called identifying graphene at all 12 independently tested locations “important validation of our technology and development approach.”

 

Why it matters

Interconnects are the microscopic copper wiring that shuttles signals around a chip. As transistors shrink, that copper gets thinner, resistance climbs, heat builds and power leaks, one of the hard ceilings on modern AI and high-performance computing. Adisyn’s pitch, via its Israeli Subsidiary 2D Generation, is that a whisker-thin graphene layer laid down at low temperature can cut that resistance without melting the delicate structures already on the chip. The critical word is temperature. Conventional graphene growth needs heat that would destroy a finished wafer; the industry’s thermal budget tops out around 450 degrees. Doing it below 300 is the whole game, and is the claim the patents and the 200mm result are built to defend.

 

The numbers that matter

Adisyn remains pre-revenue on the graphene side. Its half-year to 31 December 2025 showed a net loss of $4.56 million, cash of $4.73 million and total Assets of $47.44 million. The legacy IT and Cybersecurity arm, Adisyn Services, has been classified as held for sale; it turned over $1.9 million in the half but lost $395,000, and is being shopped or spun off so management can concentrate on chips.

The Balance Sheet was reinforced by a $14 million Placement earlier in the year, with Israeli institution Meitav and Regal Partners named among cornerstone backers, useful runway for a Business whose commercial deals are still ahead of it. The market it is chasing is large: the semiconductor interconnect segment is put at roughly US$31 billion today, and 200mm wafer output is forecast to reach about 92 million units a year by 2030.

 

The bigger industry picture

Adisyn is not working in a vacuum, and that cuts both ways. 2D Generation is a named partner in the European Union’s “Connecting Chips” joint undertaking, whose participants include Nvidia, imec and NXP, credible company for a micro-cap. Every major foundry, from TSMC to Samsung, is hunting for materials that push past copper’s limits, which is precisely why a low-temperature, drop-in-compatible process is interesting. But it also means Adisyn is one contender among well-funded rivals and in-house research teams, and the leading-edge fabs it must eventually win over move slowly and qualify new materials over years, not quarters.

 

The bull case

The appeal is a capital-light model with optionality. Adisyn does not intend to build a fab; it plans to license the technology and run joint-development programs, keeping costs down while a single binding deal with a global chipmaker could re-rate the stock. The dual patent strategy, process plus product, is designed so that even a licensee’s output infringes if it uses the coated interconnect. There is a second string, too: a graphene-based radar-absorbing “stealth” coating licensed exclusively from Tel Aviv University, with a former Iron Dome commander advising a drone division, giving Adisyn a defence angle should the semiconductor path prove long. The 200mm result, verified externally and delivered early, is the strongest evidence yet that the science travels from the lab bench toward the factory floor.

 

The risks

Treat the performance claims as claims. Independent identification of graphene on a wafer is not the same as a qualified, high-yield production process, and Adisyn concedes it still needs repeatability data, defect rates across many runs, device integration and customer sign-off before Revenue appears. It has no signed licensee, no licensing income and a modest cash balance against ongoing losses, so further Capital raising is a live possibility that could dilute holders. “Allowed” patents are not yet formally granted. And the 300mm wafers used by the biggest AI-chip makers are a further step up from the 200mm just achieved. Execution risk here is real and multi-year.

 

What happens next

Watch for these catalysts: full, uniform graphene coverage of the 200mm wafer, guided by management to “a few months,” so potentially before year-end 2026; formal grant of the two allowed US patents; a first 300mm wafer result, the format TSMC and Samsung actually run; any binding joint-development or licensing agreement with a chipmaker, the true valuation trigger; and resolution of the Adisyn Services sale, which would sharpen the company into a pure-play materials story. Repeatability and defectivity data across multiple runs will be the quiet, telling read on whether the process is manufacturable.

 

Conclusion

Adisyn has turned a laboratory curiosity into a wafer-scale demonstration in under two years, and wrapped it in patents that reach for both method and product. For a company still valued as a speculative micro-cap, that is a genuine change in the risk profile, evidence is accumulating where before there was mostly ambition. Yet the hardest yards remain. The step from a verified 200mm coupon of graphene to a qualified, contracted process inside a leading foundry is measured in years and will Demand more cash and more proof. The technology is promising and, importantly, externally checked. Whether it becomes a business now rests on customers and deals Adisyn has yet to name.